Dixon Hubard Feinour & Brown’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $8.73M | Sell |
16,063
-303
| -2% | -$165K | 1.04% | 31 |
|
|
2022
Q1 | $9.67M | Sell |
16,366
-13,254
| -45% | -$7.83M | 0.97% | 34 |
|
|
2021
Q4 | $19.8M | Buy |
29,620
+2,473
| +9% | +$1.65M | 1.9% | 6 |
|
|
2021
Q3 | $15.5M | Sell |
27,147
-2,582
| -9% | -$1.48M | 3.29% | 3 |
|
|
2021
Q2 | $15M | Sell |
29,729
-31,624
| -52% | -$16M | 3.12% | 4 |
|
|
2021
Q1 | $27.5M | Buy |
61,353
+29,829
| +95% | +$13.4M | 3.39% | 3 |
|
|
2020
Q4 | $13.9M | Hold |
31,524
| – | – | 3.57% | 3 |
|
|
2020
Q3 | $13.9M | Sell |
31,524
-913
| -3% | -$403K | 3.57% | 3 |
|
|
2020
Q2 | $13.2M | Sell |
32,437
-619
| -2% | -$252K | 3.43% | 3 |
|
|
2020
Q1 | $9.38M | Sell |
33,056
-1,375
| -4% | -$390K | 3.17% | 6 |
|
|
2019
Q4 | $11.2M | Sell |
34,431
-140
| -0.4% | -$45.5K | 2.9% | 4 |
|
|
2019
Q3 | $10.1M | Buy |
34,571
+105
| +0.3% | +$30.6K | 2.79% | 8 |
|
|
2019
Q2 | $10.1M | Buy |
34,466
+245
| +0.7% | +$72K | 2.88% | 5 |
|
|
2019
Q1 | $9.37M | Buy |
34,221
+178
| +0.5% | +$48.7K | 2.82% | 5 |
|
|
2018
Q4 | $7.62M | Sell |
34,043
-1,072
| -3% | -$240K | 2.82% | 5 |
|
|
2018
Q3 | $8.57M | Buy |
+35,115
| New | +$8.57M | 2.37% | 6 |
|
|
2016
Q4 | – | Sell |
-44,010
| Closed | -$7M | – | 185 |
|
|
2016
Q3 | $7M | Buy |
44,010
+400
| +0.9% | +$63.6K | 2.17% | 10 |
|
|
2016
Q2 | $6.44M | Buy |
+43,610
| New | +$6.44M | 2.06% | 13 |
|